Date published: 2025-12-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC388564 Inhibitors

LOC388564 inhibitors encompass a diverse range of chemicals that interface with various cellular pathways to attenuate the activity of this transmembrane protein. Amiloride, through its blockade of ENaCs, could indirectly inhibit LOC388564 by stabilizing the membrane potential, potentially rendering any ion channel activity of LOC388564 less effective or altering its conformational state. Brefeldin A disrupts vesicle trafficking, a fundamental process for the localization and function of transmembrane proteins. If LOC388564 requires proper trafficking to the plasma membrane to perform its function, the interference by Brefeldin A could result in its mislocalization and, consequently, functional inhibition. Genistein, by blocking tyrosine kinases, might inhibit phosphorylation events that regulate LOC388564, altering its activity state.

Cholesterol-binding agents, such as Nystatin, could disrupt lipid raft integrity, and if LOC388564 relies on these microdomains for its function, such disruption would be inhibitory. Fumonisin B1, by impairing sphingolipid metabolism, could affect LOC388564 if its activity is modulated by these lipids or their derivatives. Dynasore inhibits dynamin, a GTPase critical for endocytosis. Should LOC388564 be regulated through endocytic cycling, dynasore's action could result in the protein's accumulation at the cell surface and attenuate its function. Pertussis toxin's inhibition of Gi protein signaling might inhibit LOC388564 if it relies on G-protein-coupled mechanisms for its activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Amiloride

2609-46-3sc-337527
1 g
$290.00
7
(1)

Amiloride is a diuretic that blocks epithelial sodium channels (ENaCs). By inhibiting ENaCs, it can alter membrane potential and cellular ion homeostasis. If LOC388564 is an ion channel or is modulated by changes in ion concentrations, amiloride's action could reduce its activity by stabilizing the membrane potential and thus inhibiting the conductance of ions.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A is an inhibitor of ADP-ribosylation factor (ARF), a small GTPase involved in vesicle trafficking between the Golgi apparatus and the endoplasmic reticulum. If LOC388564 requires trafficking to the membrane to function, Brefeldin A could inhibit this protein by disrupting its transport to the plasma membrane.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is an inhibitor of tyrosine kinases. If LOC388564's function is regulated by phosphorylation through tyrosine kinases, genistein could indirectly inhibit its activity by preventing its phosphorylation state changes that are necessary for its activation or modulation.

Nystatin

1400-61-9sc-212431
sc-212431A
sc-212431B
sc-212431C
5 MU
25 MU
250 MU
5000 MU
$50.00
$126.00
$246.00
$3500.00
7
(1)

Cholesterol is critical for membrane fluidity and the formation of lipid rafts, which are important for the function of many transmembrane proteins. Nystatin binds to cholesterol, disrupting lipid rafts. If LOC388564 is associated with lipid rafts for its function, disrupting these structures could inhibit the protein's activity by altering its local membrane environment.

Fumonisin B1

116355-83-0sc-201395
sc-201395A
1 mg
5 mg
$117.00
$469.00
18
(1)

Fumonisin B1 inhibits ceramide synthase, leading to altered sphingolipid metabolism. Sphingolipids are crucial for membrane structure and signaling. If LOC388564 interacts with sphingolipids or is modulated by them, inhibition of ceramide synthase could inhibit the function of LOC388564 by disrupting membrane composition and associated signaling cascades.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Dynasore is a GTPase inhibitor that specifically inhibits dynamin, which is involved in endocytosis. If LOC388564 undergoes regulated internalization as part of its function, inhibition of dynamin by dynasore could prevent the endocytosis of LOC388564, thus inhibiting its functional cycling and decreasing its activity at the plasma membrane.

Oligomycin A

579-13-5sc-201551
sc-201551A
sc-201551B
sc-201551C
sc-201551D
5 mg
25 mg
100 mg
500 mg
1 g
$175.00
$600.00
$1179.00
$5100.00
$9180.00
26
(1)

Oligomycin is an inhibitor of the mitochondrial ATP synthase. By reducing ATP production, it can indirectly affect ATP-dependent transmembrane proteins. If the activity of LOC388564 is ATP-dependent, oligomycin could inhibit its function by limiting available ATP.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor. Phosphatidylinositol 3-kinase (PI3K) signaling is involved in numerous cellular processes, including trafficking and recycling of transmembrane proteins. If LOC388564 activity is dependent on PI3K signaling for its localization or recycling, LY294002 could inhibit its function by disrupting these processes.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

Pertussis toxin irreversibly disables the Gi subunit of heterotrimeric G proteins, preventing receptor-mediated inhibition of adenylate cyclase. If LOC388564 is coupled to Gi-protein signaling pathways, pertussis toxin could inhibit its functional activity by preventing G-protein-mediated signal transduction.

T16Ainh-A01

552309-42-9sc-497578
sc-497578A
10 mg
50 mg
$68.00
$277.00
(0)

T16Ainh-A01 is an inhibitor of the TMEM16A calcium-activated chloride channel. While LOC388564 is not TMEM16A, if it shares functional similarities or has a regulatory relationship with calcium-activated channels, T16Ainh-A01 could indirectly inhibit its function by altering cellular chloride and calcium dynamics that LOC388564's function may be sensitive to.